Myocardial Infarction in a Young Patient with Chronic Myeloid Leukemia after Nilotinib Use
Journal Title: International Journal of Medical and Pharmaceutical Case Reports - Year 2016, Vol 7, Issue 5
Abstract
Nilotinib is an analog of imatinib increasingly used for the treatment of imatinib-resistant chronic myeloid leukemia. It has been considered a well-tolerated drug with little side effects. The most common adverse effects to nilotinib are skin rash, pruritus, headache, nausea, and fatigue. Nilotinib-induced vascular events are rare, including peripheral artery occlusive disease, Raynaud syndrome, cerebrovascular accidents. Myocardial infarction has rarely been reported. In this paper, we describe the case of a 37-year-old female who developed a severe myocardial infarction after nilotinib use. There are two different vascular events reported with nilotinib: A progressively worsening of preexistent occluding vascular lesions and vasospastic events. In our patient, myocardial infarction seems to be secondary to severe coronary occlusive event. Nilotinib might facilitate the development of vascular events in patients with preexisting risk factors. However several patients have been shown to experience such events in the absence of any cardiovascular risk factor. The mechanism of nilotinib-induced myocardial infarction is still controversial. It is reported to be induced via mitochondrial damage, a negative effect of the substance on pre-existing atherosclerotic changes or ischaemic processes. Our report emphasizes the importance of early detection and evaluation of cardiotoxicity in order to prevent fatal consequences of such an adverse event even in young patients.
Authors and Affiliations
Neila Fathallah, Kmira Zahra, Rania Bouneb, Mohamed Mahjoub, Wafa Guetari, Monia Zaier, Chaker Ben Salem, Abderrahim Khelif
Keywords
Related Articles
- EP ID EP327721
- DOI 10.9734/IJMPCR/2016/28909
- Views 106
- Downloads 0
Adolescent Female Patient with Hip Pain: Slipped Capital Femoral Epiphysis (SCFE)
SCFE is the most common hip disorder affecting the young age between 8 and 16 year old. The prevalence of SCFE is 10 per 100,000 children. The incidence of SCFE is more on boys than girls. We would like to report a case...
An Uncommon Case of Phenibut Toxicity in an Intensive Care Unit
Gamma-aminobutyric acid (GABA) agonists are used as exogenous neuromodulators for patients with chronic pain and refractory mental illness. Phenibut is a controlled GABA-B agonist, with an extensive use in Russia for psy...
Hibernoma at Base of Neck- A Rare Case in a Six Month Old Infant
Hibernomas are very uncommon soft tissue tumors. They are composed of brown fat. They are usually seen in adults in the fourth/ fifth decades according to published literature. Very few cases in Paediatric age group have...
Functional Massage of the Teres Major Muscle in Patients with Subacromial Impingement Syndrome. A Randomized Controlled Case Series Study
Aims: Subacromial impingement syndrome is the most common shoulder condition. Myofascial trigger points in teres major muscle can be associated with this syndrome. Our objective is to determine whether adding manual ther...
A Case of Secondary Syphilis Presenting with a Vaginal Mass: A Case Report
Syphilis is an infectious venereal disease caused by the Treponema pallidum that presents with variable clinical manifestations. Herein we present an atypical case of secondary syphilis presenting with vaginal mass as th...